Main Content start here
Main Layout
Report Description

Report Description

Key Insights

Details

Forecast Period

2027-2031

Market Size (2025)

USD 2.74 Billion

CAGR (2026-2031)

5.46%

Fastest Growing Segment

Reagent

Largest Market

North

Market Size (2031)

USD 3.77 Billion

Market Overview

The India In Vitro Diagnostics Market is expected to grow from USD 2.74 Billion in 2025 to USD 3.77 Billion by 2031 at a 5.46% CAGR. In Vitro Diagnostics (IVD) encompass medical devices and reagents utilized to perform tests on biological samples collected from the human body, such as blood, urine, or tissue, facilitating disease detection, health condition monitoring, and informed clinical decision-making. The market's expansion is primarily driven by the increasing prevalence of both chronic and infectious diseases, coupled with rising healthcare expenditures and a growing public awareness regarding the benefits of early disease detection and preventive health screening. According to ICRA, the Indian diagnostic industry witnessed a year-on-year revenue growth of 16.1% in Fiscal Year 2026.

However, a significant challenge impeding market expansion is the substantial reliance on imported IVD products and instruments, with government officials highlighting a 70-80% import dependence for the sector. This dependence creates vulnerabilities in the supply chain and can lead to higher costs, potentially limiting broader access to advanced diagnostic technologies in a price-sensitive market.

Key Market Drivers

Public Health Funding Drives IVD Demand
Government healthcare initiatives and increased spending are significant catalysts for the India In Vitro Diagnostics Market. Programs such as Ayushman Bharat aim to enhance healthcare accessibility and affordability by establishing health and wellness centers and providing health insurance coverage to vulnerable populations. This expansion of public health infrastructure and financial support directly stimulates the demand for diagnostic tests and reagents across both urban and rural settings. According to the Observer Research Foundation, in February 2025, in the 'Union Budget 2025: A pulse check on healthcare' article, the government allocated INR 95,957.87 crore to the healthcare sector for Fiscal Year 2026, representing a 9.46 percent increase from the previous fiscal year's budget estimates. Such allocations are instrumental in funding diagnostic services, improving laboratory facilities, and supporting procurement of IVD products, thereby broadening market penetration.

Aging Population and Rising Middle Class Drive IVD Demand
Demographic shifts, particularly the aging population and the expansion of the middle class, further drive the demand for in vitro diagnostics in India. An increasing elderly demographic naturally leads to a higher prevalence of age-related chronic diseases, necessitating frequent diagnostic monitoring and early disease detection. Concurrently, the burgeoning middle class exhibits greater health awareness and increased disposable income, enabling them to seek out more advanced and routine diagnostic screenings. According to Scroll.in, in March 2026, in the 'India's population is growing older but with little support' article, the elderly population constituted 11% of the country's total population in 2025, significantly contributing to the overall demand for diagnostic services. This growing segment of the population, coupled with the rising affluence of the middle class, fuels a sustained demand for IVD products and services. Overall, the IVD market in India is valued at approximately USD 150 million annually for reagent kits and laboratory equipment and is expanding at 20% per annum on a compounded basis, according to the Association of Diagnostics Manufacturers of India, in 2024.

Download Free Sample Report

Key Market Challenges

Import Dependence Impedes IVD Market Growth and Elevates Costs
The substantial reliance on imported In Vitro Diagnostics (IVD) products and instruments presents a significant impediment to the growth of the India IVD market. This high import dependence creates considerable vulnerabilities within the supply chain, as disruptions in global manufacturing or logistics can severely impact the availability of essential diagnostic tests and equipment domestically. Consequently, this reliance often leads to higher procurement costs for healthcare providers, which are then passed on to patients in a highly price-sensitive market.

Import Dependence Limits Local Manufacturing, R&D, and Access to Diagnostics
This dependency directly hampers the broader accessibility of advanced diagnostic technologies across India. Local manufacturers face challenges in scaling production and innovating due to the entrenched market presence of imported goods. According to the India Brand Equity Foundation (IBEF), in August 2026, India's domestic medical device production met only 30% of the country's domestic requirements, reflecting a sustained reliance on foreign imports. This continued preference for imports curtails investment in local research and development, stifles the emergence of indigenous manufacturing capabilities, and restricts the market's overall expansion potential by making advanced diagnostics unaffordable for a significant portion of the population.

Key Market Trends

Rapid adoption of molecular and point-of-care diagnostics with scalable local production
The India In Vitro Diagnostics market is notably driven by the rapid adoption of advanced molecular and point-of-care technologies. These innovations enable quicker, more accurate, and accessible diagnostic testing, shifting from traditional centralized laboratory settings. Molecular diagnostics, including PCR, are vital for infectious disease management, oncology, and genetic screening, offering enhanced sensitivity. Point-of-care devices also provide immediate results across various healthcare settings, improving patient outcomes. This technological shift is supported by efforts to scale local production, with CUPID Limited's IVD kit production capacity at Sinnar expected to increase from 4 lakh to 8 lakh kits per day by 2027. This expansion ensures broader availability and adoption of advanced diagnostics.

Strategic shift toward domestic IVD manufacturing supported by government incentives
A pivotal trend is the growing emphasis on domestic IVD manufacturing and innovation, a strategic imperative to reduce import dependence and bolster healthcare self-reliance. This focus stimulates local research and development, fostering indigenous technological advancements and creating a more robust supply chain within India. Government support through various schemes is crucial. For example, under the Production Linked Incentive (PLI) Scheme for Medical Devices, a total incentive amount of ₹157.15 crore had been disbursed to seven applicants till December 2025, demonstrating tangible support for local manufacturers. This push for domestic production addresses cost sensitivities and enhances access to essential diagnostics.

Segmental Insights

Reagent Segment as a Pivotal Driver of India's IVD Market Growth
The Reagent segment is a pivotal and the fastest-growing component of the India In Vitro Diagnostics Market due to its essential and recurring demand in a vast array of diagnostic tests. This rapid expansion is primarily fueled by the escalating prevalence of both chronic and infectious diseases across the country, necessitating frequent and early diagnosis. Furthermore, continuous advancements in diagnostic technologies, including molecular diagnostics and point-of-care testing, require a constant supply of specialized reagents. Government initiatives aimed at enhancing healthcare accessibility and the expansion of diagnostic laboratory networks into underserved regions also contribute significantly to the sustained high consumption of these critical consumables, all while adhering to the regulatory standards set by the Central Drugs Standard Control Organization (CDSCO).

Regional Insights

North India Emerges as the Dominant IVD Market
North India emerges as the dominant region in the India In Vitro Diagnostics market, driven by several distinct factors. The region's substantial population density provides a vast pool of potential patients, naturally increasing the demand for diagnostic services. Concurrently, North India, particularly the National Capital Region, boasts a more developed healthcare infrastructure, characterized by a higher concentration of hospitals, clinics, and advanced diagnostic laboratories that actively utilize IVD products. Economic vibrancy in major northern cities further fuels greater healthcare expenditure, including diagnostics, among the urban and semi-urban populations. Additionally, governmental programs aimed at expanding healthcare accessibility contribute significantly to the market's robust growth in the area.

Recent Developments

  • In March 2025, HaystackAnalytics launched 'TB One,' a Make-in-India solution designed to improve tuberculosis (TB) diagnosis across the nation. This offering enables Next-Generation Sequencing (NGS) in diagnostic laboratories and hospitals, including a pre-sequencing kit for Whole Genome Sequencing and access to HaystackAnalytics' patented clinical reporting software, 'Omega TB.' The solution aims to make genomics-based TB testing more accessible and scalable without requiring significant infrastructure changes, thereby enhancing drug resistance profiling and strengthening India's efforts against TB.
  • In May 2024, MolBio Diagnostics announced plans to introduce new point-of-care technologies for the Indian market, focusing on areas such as haematology, cancer, and antimicrobial resistance. Additionally, MolBio Diagnostics collaborated with Niramai Health Analytix, a deep-tech startup, to accelerate the adoption of Niramai’s AI-based, non-invasive breast cancer screening solution. This partnership aims to enhance women's healthcare by offering advanced cancer screening tools, including MolBio’s cervical cancer tests, expanding access to crucial diagnostics within the India In Vitro Diagnostics Market.
  • In March 2024, Fapon showcased its innovative in vitro diagnostic technologies and comprehensive solutions at Medical Fair India in Mumbai. The global life sciences company introduced new biomarkers, blockers, bulk reagents, assays, and instrument platforms designed to meet the evolving requirements of the local healthcare sector. Fapon aimed to empower Indian IVD manufacturers by providing essential raw materials, reliable bulk reagents, open-instrument platforms, and technical assistance. This initiative was intended to support domestic companies in developing advanced diagnostic tests, thereby strengthening the India In Vitro Diagnostics Market.
  • In January 2024, Siemens Healthineers and the Indian Institute of Science (IISc) inaugurated the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine in Bengaluru. This collaboration focuses on developing open-source artificial intelligence tools to precisely automate the segmentation of pathological findings in neuroimaging data, aiming to enhance the accurate diagnosis of neurological diseases and analyze their clinical impact at a population level in India. The initiative, supported by Siemens Healthineers' Corporate Social Responsibility efforts, also includes fellowships for women to increase female representation in artificial intelligence.

Key Market Players

  • Abbott India Limited
  • Danaher (DHR) Holding India Pvt Limited
  • Roche Diagnostics India Pvt. Ltd.
  • bioMérieux India Private Limited
  • Transasia Bio-Medicals Ltd.
  • bioMérieux India Limited
  • Becton Dickinson Private Limited
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Siemens Healthcare Private Limited
  • Sysmex India Pvt. Ltd

By Product

By Test Type

By Usability

By Application

By End User

By Region

  • Instrument
  • Reagent
  • Other Products
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Immuno Diagnostics
  • Other Types
  • Disposable In Vitro Diagnostics Devices
  • Reusable In Vitro Diagnostics Devices
  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others
  • North India
  • East India
  • West India
  • South India

Report Scope:

In this report, the India In Vitro Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • India In Vitro Diagnostics Market, By Product:
  • Instrument
  • Reagent
  • Other Products
  • India In Vitro Diagnostics Market, By Test Type:
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Immuno Diagnostics
  • Other Types
  • India In Vitro Diagnostics Market, By Usability:
  • Disposable In Vitro Diagnostics Devices
  • Reusable In Vitro Diagnostics Devices
  • India In Vitro Diagnostics Market, By Application:
  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others
  • India In Vitro Diagnostics Market, By End User:
  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others
  • India In Vitro Diagnostics Market, By Region:
  • North India
  • East India
  • West India
  • South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India In Vitro Diagnostics Market.

Available Customizations:

India In Vitro Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India In Vitro Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    India In Vitro Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Product (Instrument, Reagent, Other Products)

5.2.2.  By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other Types)

5.2.3.  By Usability (Disposable In Vitro Diagnostics Devices, Reusable In Vitro Diagnostics Devices)

5.2.4.  By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others)

5.2.5.  By End User (Diagnostic Laboratories, Hospitals & Clinics, Others)

5.2.6.  By Region

5.2.7.  By Company (2025)

5.3.  Market Map

6.    North In Vitro Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product

6.2.2.  By Test Type

6.2.3.  By Usability

6.2.4.  By Application

6.2.5.  By End User

7.    East In Vitro Diagnostics Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Product

7.2.2.  By Test Type

7.2.3.  By Usability

7.2.4.  By Application

7.2.5.  By End User

8.    West In Vitro Diagnostics Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Product

8.2.2.  By Test Type

8.2.3.  By Usability

8.2.4.  By Application

8.2.5.  By End User

9.    South In Vitro Diagnostics Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Product

9.2.2.  By Test Type

9.2.3.  By Usability

9.2.4.  By Application

9.2.5.  By End User

10.    Market Dynamics

10.1.  Drivers

10.2.  Challenges

11.    Market Trends & Developments

11.1.  Merger & Acquisition (If Any)

11.2.  Product Launches (If Any)

11.3.  Recent Developments

12.    Competitive Landscape

12.1.  Abbott India Limited

12.1.1.  Business Overview

12.1.2.  Products & Services

12.1.3.  Recent Developments

12.1.4.  Key Personnel

12.1.5.  SWOT Analysis

12.2.  Danaher (DHR) Holding India Pvt Limited

12.3.  Roche Diagnostics India Pvt. Ltd.

12.4.  bioMérieux India Private Limited

12.5.  Transasia Bio-Medicals Ltd.

12.6.  bioMérieux India Limited

12.7.  Becton Dickinson Private Limited

12.8.  Thermo Fisher Scientific India Pvt. Ltd.

12.9.  Siemens Healthcare Private Limited

12.10.  Sysmex India Pvt. Ltd

13.    Strategic Recommendations

14.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the India In Vitro Diagnostics Market was estimated to be USD 2.74 Billion in 2025.

North is the dominating region in the India In Vitro Diagnostics Market.

Reagent segment is the fastest growing segment in the India In Vitro Diagnostics Market.

The India In Vitro Diagnostics Market is expected to grow at 5.46% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.